PolyPid (PolyPid) Beginning Cash Position : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is PolyPid Beginning Cash Position?

PolyPid's Beginning Cash Position for the quarter that ended in Dec. 2023 was $0.00 Mil.

PolyPid's annual Beginning Cash Position increased from Dec. 2021 ($4.91 Mil) to Dec. 2022 ($10.46 Mil) but then declined from Dec. 2022 ($10.46 Mil) to Dec. 2023 ($9.14 Mil).

PolyPid Beginning Cash Position Historical Data

The historical data trend for PolyPid's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPid Beginning Cash Position Chart

PolyPid Annual Data

Trend

Dec12

Dec13

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

7.77

4.50

4.91

10.46

9.14

PolyPid Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

PolyPid Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

PolyPid Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of PolyPid's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPid (PolyPid) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PolyPid Ltd (NAS:PYPD) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Hasivim Street, P.O Box 7126, Petach Tikva, ISR, 495376

Website

https://www.polypid.com

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, and Bacyssio are trademarks of the company. The company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.